Drugmakers to join forces to make millions of Ebola vaccine doses

Leading drugmakers plan to work together to speed up the development of an Ebola vaccine and hope to produce millions of doses for use next year.

Johnson & Johnson halts sale of device used in fibroid surgery

American pharmaceutical giant Johnson & Johnson has suspended sales of the devices used in fibroid surgery amid concerns about their potential to spread a rare but deadly cancer, reported The Wall Street Journal.

EU backs J&J`s TB drug, postpones decision on Teva MS pill

European regulators on Friday recommended approval of an innovative tuberculosis drug from Johnson & Johnson but postponed a keenly awaited decision on a new multiple sclerosis pill from Teva Pharmaceutical Industries.

J&J to pay $2.2 bn to end US drug probes

Global healthcare giant Johnson & Johnson and its subsidiaries have agreed to pay more than $2.2 billion to resolve criminal and civil investigations for misbranding anti-psychotic drugs and paying kickbacks to pharmacists, the US Department of Justice said.

FDA approves new tuberculosis drug

The drug named Sirturo - known chemically as bedaquilineas – is an alternative treatment for adults suffering from TB.

Johnson & Johnson in trouble

Johnson & Johnson is facing a multi-million-pound legal claim for faulty hip replacement operations.

Johnson & Johnson in trouble

Johnson & Johnson is facing a multi-million-pound legal claim for faulty hip replacement operations.

Johnson & Johnson to cut more than 7,000 jobs worldwide

Johnson & Johnson, a leading US health care products company, said on Tuesday that it will slash between six and seven percent of its global workforce, more than 7,000 jobs, to cut costs.